Skip to content
Research/Peptide Blends Stacks/FOXO4-DRI + SS-31 + Epithalon

FOXO4-DRI + SS-31 + Epithalon

Cellular Longevity blend. Advanced longevity blend targeting senescent cells (FOXO4-DRI), mitochondrial protection (SS-31), and telomere extension (Epithalon). Senolytic, mitochondria, telomere, cellular rejuvenation.

Intelligence Profile

Science

Mechanism of Action

Limited Evidence Available

No peer-reviewed research or clinical trial data was retrieved for the specific combination of FOXO4-DRI + SS-31 + Epithalon. Without published scientific evidence, the precise mechanism of action for this three-compound combination cannot be established.

While individual components may have theoretical mechanisms based on separate research:

  • FOXO4-DRI (FOXO4-D-Retro-Inverso) has been studied as a senolytic peptide in some preclinical models
  • SS-31 (elamipretide) is a mitochondrial-targeted peptide that has undergone clinical investigation
  • Epithalon is a synthetic peptide that has been the subject of limited research

However, no scientific literature exists documenting how these compounds might work together, their combined effects, potential synergistic mechanisms, or safety profile as a combination therapy.

Clinical Significance: The absence of published research on this specific combination means that any claims about mechanism of action, efficacy, or safety cannot be supported by peer-reviewed evidence at this time.

This information is for educational purposes only and does not constitute medical advice. Consult healthcare professionals before considering any experimental treatments.